These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 17428320)
1. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Broeks A; Braaf LM; Huseinovic A; Nooijen A; Urbanus J; Hogervorst FB; Schmidt MK; Klijn JG; Russell NS; Van Leeuwen FE; Van 't Veer LJ Breast Cancer Res; 2007; 9(2):R26. PubMed ID: 17428320 [TBL] [Abstract][Full Text] [Related]
2. Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in Yadav S; Boddicker NJ; Na J; Polley EC; Hu C; Hart SN; Gnanaolivu RD; Larson N; Holtegaard S; Huang H; Dunn CA; Teras LR; Patel AV; Lacey JV; Neuhausen SL; Martinez E; Haiman C; Chen F; Ruddy KJ; Olson JE; John EM; Kurian AW; Sandler DP; O'Brien KM; Taylor JA; Weinberg CR; Anton-Culver H; Ziogas A; Zirpoli G; Goldgar DE; Palmer JR; Domchek SM; Weitzel JN; Nathanson KL; Kraft P; Couch FJ J Clin Oncol; 2023 Mar; 41(9):1703-1713. PubMed ID: 36623243 [TBL] [Abstract][Full Text] [Related]
3. Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer. Reiner AS; Robson ME; Mellemkjær L; Tischkowitz M; John EM; Lynch CF; Brooks JD; Boice JD; Knight JA; Teraoka SN; Liang X; Woods M; Shen R; Shore RE; Stram DO; Thomas DC; Malone KE; Bernstein L; Riaz N; Woodward W; Powell S; Goldgar D; Concannon P; ; Bernstein JL J Natl Cancer Inst; 2020 Dec; 112(12):1275-1279. PubMed ID: 32119081 [TBL] [Abstract][Full Text] [Related]
4. [The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic]. Pohlreich P; Kleibl Z; Kleiblová P; Janatová M; Soukupová J; Macháčková E; Házová J; Vašíčková P; Sťahlová Hrabincová E; Navrátilová M; Svoboda M; Foretová L Klin Onkol; 2012; 25 Suppl():S59-66. PubMed ID: 22920209 [TBL] [Abstract][Full Text] [Related]
5. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Bernstein JL; Thomas DC; Shore RE; Robson M; Boice JD; Stovall M; Andersson M; Bernstein L; Malone KE; Reiner AS; Lynch CF; Capanu M; Smith SA; Tellhed L; Teraoka SN; Begg CB; Olsen JH; Mellemkjaer L; Liang X; Diep AT; Borg A; Concannon P; Haile RW; Eur J Cancer; 2013 Sep; 49(14):2979-85. PubMed ID: 23706288 [TBL] [Abstract][Full Text] [Related]
6. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P; J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132 [TBL] [Abstract][Full Text] [Related]
7. The spectrum of ATM missense variants and their contribution to contralateral breast cancer. Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301 [TBL] [Abstract][Full Text] [Related]
8. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444 [TBL] [Abstract][Full Text] [Related]
9. Gene-gene interactions in breast cancer susceptibility. Turnbull C; Seal S; Renwick A; Warren-Perry M; Hughes D; Elliott A; Pernet D; Peock S; Adlard JW; Barwell J; Berg J; Brady AF; Brewer C; Brice G; Chapman C; Cook J; Davidson R; Donaldson A; Douglas F; Greenhalgh L; Henderson A; Izatt L; Kumar A; Lalloo F; Miedzybrodzka Z; Morrison PJ; Paterson J; Porteous M; Rogers MT; Shanley S; Walker L; ; Ahmed M; Eccles D; Evans DG; Donnelly P; Easton DF; Stratton MR; Rahman N Hum Mol Genet; 2012 Feb; 21(4):958-62. PubMed ID: 22072393 [TBL] [Abstract][Full Text] [Related]
10. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Bernstein JL; Langholz B; Haile RW; Bernstein L; Thomas DC; Stovall M; Malone KE; Lynch CF; Olsen JH; Anton-Culver H; Shore RE; Boice JD; Berkowitz GS; Gatti RA; Teitelbaum SL; Smith SA; Rosenstein BS; Børresen-Dale AL; Concannon P; Thompson WD; Breast Cancer Res; 2004; 6(3):R199-214. PubMed ID: 15084244 [TBL] [Abstract][Full Text] [Related]
11. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067 [TBL] [Abstract][Full Text] [Related]
12. Histopathological features of breast cancer in carriers of ATM gene variants. Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299 [TBL] [Abstract][Full Text] [Related]
15. Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study. Mellemkjaer L; Dahl C; Olsen JH; Bertelsen L; Guldberg P; Christensen J; Børresen-Dale AL; Stovall M; Langholz B; Bernstein L; Lynch CF; Malone KE; Haile RW; Andersson M; Thomas DC; Concannon P; Capanu M; Boice JD; ; Bernstein JL Br J Cancer; 2008 Feb; 98(4):728-33. PubMed ID: 18253122 [TBL] [Abstract][Full Text] [Related]
16. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Baynes C; Healey CS; Pooley KA; Scollen S; Luben RN; Thompson DJ; Pharoah PD; Easton DF; Ponder BA; Dunning AM; Breast Cancer Res; 2007; 9(2):R27. PubMed ID: 17428325 [TBL] [Abstract][Full Text] [Related]
17. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. Johnson N; Fletcher O; Palles C; Rudd M; Webb E; Sellick G; dos Santos Silva I; McCormack V; Gibson L; Fraser A; Leonard A; Gilham C; Tavtigian SV; Ashworth A; Houlston R; Peto J Hum Mol Genet; 2007 May; 16(9):1051-7. PubMed ID: 17341484 [TBL] [Abstract][Full Text] [Related]
18. Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk. Kaufmann WK; Filatov L; Oglesbee SE; Simpson DA; Lotano MA; McKeen HD; Sawyer LR; Moore DT; Millikan RC; Cordeiro-Stone M; Carey LA Carcinogenesis; 2006 Dec; 27(12):2519-27. PubMed ID: 16777992 [TBL] [Abstract][Full Text] [Related]
19. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer. Hirsch AE; Atencio DP; Rosenstein BS Breast Cancer Res Treat; 2008 Jan; 107(1):139-44. PubMed ID: 17333338 [TBL] [Abstract][Full Text] [Related]
20. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy. Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]